News Related to Chronic Autoimmune Disease

Related coverage linked through entity extraction aliases.

Feinstein Institutes unveils peptide therapy for sepsis and rheumatoid arthritis

Feb 19, 2026

Scientists at Northwell Health's Feinstein Institutes have developed a novel drug discovery strategy transforming a detrimental immune element into a therapeutic for sepsis and rheumatoid arthritis, published in Military Medical Research.

BioNxt Secures European Patent for Sublingual Cladribine Drug Delivery Technology

Feb 17, 2026

BioNxt Solutions Inc. receives European Patent No. 4539857 for its proprietary sublingual cladribine oral thin film drug delivery technology, providing protection across up to 39 European Patent Convention states through at least June 14, 2043.